Jon P. Stonehouse

2012

In 2012, Jon P. Stonehouse earned a total compensation of $1.2M as President, Chief Executive Officer and Director at BioCryst Pharmaceuticals, a 2% decrease compared to previous year.

Compensation breakdown

Option Awards$612,076
Salary$461,860
Stock Awards$157,287
Other$13,405
Total$1,244,628

Stonehouse received $612.1K in option awards, accounting for 49% of the total pay in 2012.

Stonehouse also received $461.9K in salary, $157.3K in stock awards and $13.4K in other compensation.

Rankings

In 2012, Jon P. Stonehouse's compensation ranked 5,281st out of 11,487 executives tracked by ExecPay. In other words, Stonehouse earned more than 54.0% of executives.

ClassificationRankingPercentile
All
5,281
out of 11,487
54th
Division
Manufacturing
1,850
out of 4,253
57th
Major group
Chemicals And Allied Products
445
out of 1,198
63rd
Industry group
Drugs
292
out of 920
68th
Industry
Biological Products, Except Diagnostic Substances
50
out of 160
69th
Source: SEC filing on April 10, 2015.

Stonehouse's colleagues

We found four more compensation records of executives who worked with Jon P. Stonehouse at BioCryst Pharmaceuticals in 2012.

2012

William Sheridan

BioCryst Pharmaceuticals

Chief Medical Officer

2012

Yarlagadda Babu

BioCryst Pharmaceuticals

Senior Vice President of Drug Discovery

2012

Thomas Staab

BioCryst Pharmaceuticals

Chief Financial Officer

2012

David McCullough

BioCryst Pharmaceuticals

Vice President, Strategic Planning, Commercialization and Corporate Development

News

You may also like